タイトル | A Crystal Structure Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides. |
---|
ジャーナル・号・ページ | Mol. Pharm., Vol. 14, Page 3987-3997, Year 2017 |
---|
掲載日 | 2016年6月26日 (構造データの登録日) |
---|
著者 | Maize, K.M. / Shah, R. / Strom, A. / Kumarapperuma, S. / Zhou, A. / Wagner, C.R. / Finzel, B.C. |
---|
リンク | Mol. Pharm. / PubMed:28968488 |
---|
手法 | X線回折 |
---|
解像度 | 1.13 - 2.1 Å |
---|
構造データ | PDB-5kly: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant adenosine nucleoside phosphoramidate substrate complex 手法: X-RAY DIFFRACTION / 解像度: 1.3 Å PDB-5klz: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) AMP catalytic product complex 手法: X-RAY DIFFRACTION / 解像度: 1.5 Å PDB-5km0: Human Histidine Triad Nucleotide Binding Protein 1 (hHint) IMP complex 手法: X-RAY DIFFRACTION / 解像度: 1.533 Å PDB-5km1: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) GMP catalytic product complex 手法: X-RAY DIFFRACTION / 解像度: 1.65 Å PDB-5km2: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) CMP catalytic product complex 手法: X-RAY DIFFRACTION / 解像度: 1.25 Å PDB-5km3: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) UMP catalytic product complex 手法: X-RAY DIFFRACTION / 解像度: 1.2 Å PDB-5km4: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1)-5-Iodo-UMP complex 手法: X-RAY DIFFRACTION / 解像度: 1.4 Å PDB-5km5: Human Histidine Triad Nucleotide Binding Protein 2 (hHint2) triciribine 5'-monoposphate catalytic product complex 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-5km6: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant Ara-A nucleoside phosphoramidate substrate complex 手法: X-RAY DIFFRACTION / 解像度: 1.6 Å PDB-5km8: Human Histidine Triad Nucleotide Binding Protein 2 (hHint2) Cidofovir complex 手法: X-RAY DIFFRACTION / 解像度: 2 Å PDB-5km9: Human Histidine Triad Nucleotide Binding Protein 2 (hHint2) adenosine complex 手法: X-RAY DIFFRACTION / 解像度: 1.45 Å PDB-5kma: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside D-Trp phosphoramidate substrate complex 手法: X-RAY DIFFRACTION / 解像度: 1.55 Å PDB-5kmb: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside L-Trp phosphoramidate substrate complex 手法: X-RAY DIFFRACTION / 解像度: 1.6 Å PDB-5wa8: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside L-Ala phosphoramidate substrate complex 手法: X-RAY DIFFRACTION / 解像度: 1.3 Å PDB-5wa9: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside D-Ala phosphoramidate substrate complex 手法: X-RAY DIFFRACTION / 解像度: 1.15 Å PDB-6b42: Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) 2'-deoxy-AMP complex at 1.13A resolution 手法: X-RAY DIFFRACTION / 解像度: 1.13 Å |
---|
化合物 | ChemComp-TR5: 5-methyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine / トリシリビンホスファ-ト
ChemComp-6US: [(2~{R},3~{S},4~{S},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[2-(1~{H}-indol-3-yl)ethyl]phosphonamidic acid
ChemComp-L8P: ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid / シドホビル / 薬剤, 抗ウイルス剤*YM
ChemComp-777: [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-3~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-ethyl-phosphonamidic acid
ChemComp-6UT: [(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[(2~
ChemComp-9ZA: [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[(2~{S})-1-methoxy-1-oxidanylidene-propan-2-yl]phosphonamidic acid / N-(5′-アデニリル)アラニン1-メチル
ChemComp-9ZD: [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[(2~{R})-1-methoxy-1-oxidanylidene-propan-2-yl]phosphonamidic acid
|
---|
由来 | - homo sapiens (ヒト)
|
---|
キーワード | HYDROLASE / HINT / histidine triad / HIT |
---|